Literature DB >> 2323103

Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.

K A Davies1, P Mathieson, C G Winearls, A J Rees, M J Walport.   

Abstract

A patient developed serum sickness and acute renal failure following therapy with streptokinase for myocardial ischaemia. There was a previous history of a cellulitic infection of the leg, and antibodies to streptokinase were measurable in a serum sample taken from the patient before therapy. A cryoglobulin was detected at the time of presentation with serum sickness. This contained polyclonal IgG (with anti-streptokinase activity), streptokinase, and C3. Circulating immune complexes were demonstrated by C1q-binding assay. Deposition of C3 was observed in skin and renal biopsies, and bound to erythrocytes. Renal histology, however, showed acute tubular necrosis, with no vasculitis or inflammatory cell infiltrate. This case provides an unusual example of the characterization of an immune complex comprising a specific antibody and an exogenous antigen, and has clinical implications for the use of streptokinase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323103      PMCID: PMC1535218          DOI: 10.1111/j.1365-2249.1990.tb06445.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  [Antistreptokinase and streptokinase resistance].

Authors:  R GROSS; W HARTL
Journal:  Klin Wochenschr       Date:  1962-08-15

Review 2.  Interaction of antibodies with renal cell surface antigens.

Authors:  J R Brentjens; G Andres
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

3.  Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase.

Authors:  J Noel; L H Rosenbaum; V Gangadharan; J Stewart; G Galens
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

4.  Treatment of deep-vein thrombosis with streptokinase.

Authors:  V V Kakkar; C Flanc; M J O'Shea; P T Flute; C T Howe; M B Clarke
Journal:  Br J Surg       Date:  1969-03       Impact factor: 6.939

5.  Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex-mediated damage.

Authors:  K G McGrath; B Zeffren; J Alexander; K Kaplan; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1985-09       Impact factor: 10.793

6.  Myocardial infarction: the first 24 hours.

Authors:  D P Lipkin; C J Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

7.  Streptokinase-induced anaphylactic reaction.

Authors:  T G Baumgartner; R G Davis
Journal:  Clin Pharm       Date:  1982 Sep-Oct

8.  Anaphylactic reactivity to streptokinase.

Authors:  K G McGrath; R Patterson
Journal:  JAMA       Date:  1984-09-14       Impact factor: 56.272

9.  Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1).

Authors:  N Hogg; G D Ross; D B Jones; M Slusarenko; M J Walport; P J Lachmann
Journal:  Eur J Immunol       Date:  1984-03       Impact factor: 5.532

10.  Identification of patients at risk for anaphylaxis due to streptokinase.

Authors:  M S Dykewicz; K G McGrath; R Davison; K J Kaplan; R Patterson
Journal:  Arch Intern Med       Date:  1986-02
View more
  6 in total

1.  Rhabdomyolysis and multiple system organ failure with streptokinase.

Authors:  H E Montgomery; C W McIntyre; M K Almond; K Davies; C W Pumphrey; D Bennett
Journal:  BMJ       Date:  1995-12-02

2.  Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.

Authors:  Y Birnbaum; B Strasberg; E Rechavia; Y Neuman; B Stahl
Journal:  West J Med       Date:  1993-04

3.  Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.

Authors:  O Reyes; I Torrens; A G Ojalvo; A Seralena; H E Garay
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

4.  Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.

Authors:  R Fears; H Ferres; E Glasgow; R Standring; K J Hogg; J D Gemmill; J M Burns; A P Rae; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1992-08

5.  Effect of antivenom therapy of Rhabdophis tigrinus (Yamakagashi snake) bites.

Authors:  Toru Hifumi; Atsushi Sakai; Akihiko Yamamoto; Masahiro Murakawa; Manabu Ato; Keigo Shibayama; Hiroshi Kato; Yuichi Koido; Junichi Inoue; Yuko Abe; Kenya Kawakita; Masanobu Hagiike; Akihiko Ginnaga; Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2014-07-31

Review 6.  Venomous snake bites: clinical diagnosis and treatment.

Authors:  Toru Hifumi; Atsushi Sakai; Yutaka Kondo; Akihiko Yamamoto; Nobuya Morine; Manabu Ato; Keigo Shibayama; Kazuo Umezawa; Nobuaki Kiriu; Hiroshi Kato; Yuichi Koido; Junichi Inoue; Kenya Kawakita; Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2015-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.